Role of protein kinase C in the expression of endothelin converting enzyme-1

Endocrinology

Volumn 150, Issue 3, 2009, Pages 1440-1449

  Khamaisi, Mogher ^a   Dahan, Rachel ^a   Hamed, Saher ^b   Abassi, Zaid ^b   Heyman, Samuel N ^a   Raz, Itamar ^a  

^a HEBREW UNIVERSITY   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CCAAT ENHANCER BINDING PROTEIN DELTA; CYCLIN D1; ESTROGEN; INHIBITOR OF DIFFERENTIATION 2; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PROGESTERONE; PROGESTERONE RECEPTOR B; PROTEIN P21; STAT5A PROTEIN; WNT4 PROTEIN; ASPARTIC PROTEINASE; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN-CONVERTING ENZYME 1; GLUCOSE; ISOENZYME; METALLOPROTEINASE; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HORMONAL REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; STRAIN DIFFERENCE; CELL CULTURE; DIABETES MELLITUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME SPECIFICITY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPERGLYCEMIA; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ASPARTIC ENDOPEPTIDASES; CELLS, CULTURED; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENDOTHELINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE; HUMANS; HYPERGLYCEMIA; ISOENZYMES; METALLOENDOPEPTIDASES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 62749200456     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0524     Document Type: Article

References (49)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977-986
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet [Erratum (1999) 354:602] 352:837-853
3. Brownlee M 2001 Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820
4. Koya D, King GL 1998 Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866
5. Itoh Y, Nakai A, Kakizawa H, Makino M, Fujiwara K, Kobayashi T, Kato T, Nagata M, Oda N, Katsumata H, Nagasaka A, Itoh M 2001 Alteration of endothelin-1 concentration in STZ-induced diabetic rat nephropathy. Effects of a PGI (2) derivative. Horm Res 56:165-171
6. Haak T, Jungmann E, Felber A, Hillmann U, Usadel KH 1992 Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hy- pertens 5:161-166
7. Clark BA, Kim D, Epstein FH 1997 Endothelin and atrial natriuretic peptide levels following radiocontrast exposure in humans. Am J Kidney Dis30:82-86
8. Yamauchi T, Ohnaka K, Takayanagi R, Umeda F, Nawata H 1990 Enhanced secretionofendothelin-1 byelevated glucose levels from cultured bovine a ortic endothelial cells. FEBS Lett 267:16-18
9. Park JY, Takahara N, Gabriele TA, Chou E, Naruse K, Suzuma K, Yamauchi T, Ha SW, Meier M, Rhodes CJ, King GL 2000 Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes 49:1239 -1248
10. Takei K, Sato T, Nonoyama T, Hommura S, Miyauchi T, Goto K 1993 Analysis of vasocontractile responses to endothelin-1 in rabbit retinal vessels using an ETAreceptor antagonistand an ETB receptor agonist. Life Sci 53:PL111-PL115
11. Cameron NE, Cotter MA 1996 Effects of a non-peptide endothelin-1 ET-A antagonist on neurovascular function in diabetic rats: interaction with the rennin angiotensin system. J Pharmacol Exp Ther 278:1262-1268
12. Yang Z, Li JC 2008 Stimulationofendothelin-1 gene expression by insulin via phosphoinositide-3 kinase-glycogen synthase kinase-3/3 signaling in endothelial cells. Life Sci 82:512-518
13. Hargrove GM, Dufresne J, Whiteside C, Muruve DA, Wong NC 2000 Diabetes mellitus increases endothelin-1 gene transcription in rat kidney. Kidney Int 58:1534-1545
14. Harris AK, Hutchinson JR, Sachidanandam K, Johnson MH, Dorrance AM, Stepp DW, Fagan SC, Ergul A 2005 Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1. Diabetes 54:2638 -2644
15. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, de Wit D, Yanagisawa M1994 ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473-485
16. Schmidt M, Kröger B, Jacob E, Seulberger H, Subkowski T, Otter R, Meyer T, Schmalzing G, Hillen H 1994 Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett 356:238-243
17. Turner AJ, Barnes K, Schweizer A, Valdenaire O 1998 Isoforms of endothelin- converting enzyme: why and where? Trends Pharmacol Sci 19:483-486
18. Muller L, Barret A, Etienne E, Meidan R, Valdenaire O, Corvol P, Tougard C 2003 Heterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloprotease. J Biol Chem 278:545-555
19. Khamaisi M, Raz I, Shilo V, Shina A, Rosenberger C, Dahan R, Meidan R, Abassi Z, Heyman SN 2008 Diabetes and radiocontrast media increase en- dothelin converting enzyme-1 in the kidney. Kidney Int 74:91-100
20. Keynan S, Khamaisi M, Dahan R, Barnes K, Jackson CD, Turner AJ, Raz I 2004 Increased expression of endothelin-converting enzyme-1c isoform in response to high glucose levels in endothelial cells. J Vasc Res 41:131-140
21. Su W, Dai DZ, Liu HR, Na T, Dai Y 2007 Upregulated endothelin system in diabetic vascular dysfunction and early retinopathy is reversed by CPU0213 and total triterpene acids from Fructus Corni. Clin Exp Pharmacol Physiol 34:1228-1233
22. Masatsugu K, Itoh H, Chun TH, Saito T, Yamashita J, Doi K, Inoue M, Sawada N, Fukunaga Y, Sakaguchi S, Sone M, Yamahara K, Yurugi T, Nakao K 2003 Shear stress attenuates endothelin and endothelin-converting enzyme expression through oxidative stress. Regul Pept 111:13-19
23. Williams B, Schrier RW 1992 Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes 41:1464-1472
24. Edgell CJ, McDonald CC, Graham JB 1983 Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80:3734-2737
25. Waxman L, Doshi KP, Gaul SL, Wang S, Bednar RA, Stern AM 1994 Identification and characterization of endothelin converting activity from EAHY 926 cells: evidence for the physiologically relevant human enzyme. Arch Bio-chem Biophys 308:240-253
26. Tabakman R, Lazarovici P, Kohen R 2002 Neuroprotective effects of car- nosine and homocarnosine on pheochromocytoma PC12 cells exposed toischemia. J Neurosci Res 68:463-469
27. Meidan R, Klipper E, Gilboa T, Muller L, Levy N 2005 Endothelin-converting enzyme-1, abundance of isoforms a-d and identification of a novel alternatively spliced variant lacking a transmembrane domain. J Biol Chem 280:40867-40874
28. Yokota T, Ma RC, Park JY, Isshiki K, Sotiropoulos KB, Rauniyar RK, Bornfeldt KE, King GL 2003 Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes. Diabetes 52:838-845
29. Aiello LP, Robinson GS, Lin YW, Nishio Y, King GL 1994 Identification of multiple genes in bovine retinal pericytes altered by exposure to elevated levels of glucose by using mRNA differential display. Proc Natl Acad Sci USA 91:6231-6235
30. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL1996Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 272:728-731
31. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL1997 Characterization of protein kinase Cβ isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126
32. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, Marks F 1994 Rottler in, anovel protein kinase inhibitor. Biochem Biophys Res Commun 199:93-98
33. Becker TC, Beltrandel Rio H, Noel RJ, Johnson JH, Newgard CB 1994 Over- expression of hexokinase I in isolated islets of Langerhans via recombinant adenovirus. Enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels. J Biol Chem 269:21234-21238
34. Becker TC, Noel RJ, Coats WS, Gomez-Foix AM, Alam T, Gerard RD, Newgard CB 1994 Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 43:161-189
35. Santaniello A, Salazar G, Lenna S, Antonioli R, Colombo G, Beretta L, Scorza R 2006 HLA-B35 upregulates the production of endothelin-1 in HLA-trans- fected cells: a possible pathogenetic role in pulmonary hypertension. Tissue Antigens 68:239-244
36. Heyman SN, Clark BA, Kaiser N, Spokes K, Rosen S, Brezis M, Epstein FH 1992 Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 3:58-65
37. Jirousek MR, Gillig JR, Gonzalez CM, Heath WF, McDonald 3rd JH, Neel DA, Rito CJ, Singh U, Stramm LE, Melikian-Badalian A, Baevsky M, Ballas LM, Hall SE, Winneroski LL, Faul MM 1996(S)-13 [(dimethylamino)methyl]- 0, 11, 14, 15-tetrahydro-4, 9:16, 21-dimetheno-1H, 13H-dibenzo[e, k]pyr- rolo[3, 4-h] [1,4,13]oxadiazacyclohexadecene-1, 3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C. J Med Chem 39:2664-2671
38. Klinger JR, Murray JD, Casserly B, Alvarez DF, King JA, An SS, Choudhary G, Owusu-Sarfo AN, Warburton R, Harrington EO 2007 Rottlerin causes pulmonary edema in vivo: a possible role for PKC 8. J Appl Physiol 103:2084-2094
39. Xia L, Wang H, Munk S, Frecker H, Goldberg HJ, Fantus IG, Whiteside CI 2007 Reactive oxygen species, PKC-β 1, and PKC-zeta mediate high-glucose- induced vascular endothelial growth factor expression in mesangial cells. Am J Physiol Endocrinol Metab 293:E1280-E1288
40. Chakraborti T, Das S, Chakraborti S 2005 Proteolytic activation of protein kinase Cα by peroxynitrite in stimulating cytosolic phospholipase A2 in pulmonary endothelium: involvement of a pertussis toxin sensitive protein. Biochemistry 44:5246-5257
41. Ortmann J, Nett PC, Celeiro J, Hofmann-Lehmann R, Tornillo L, Terracciano LM, Barton M 2006 Downregulation of renal endothelin-converting enzyme 2 expression in early autoimmune diabetes. Exp Biol Med (Maywood) 231:1030-1033
42. Haynes WG, Ferro CE,Webb DJ1995 Physiologic role of endothelin in maintenance of vascular tone in humans. J Cardiovasc Pharmacol 26(Suppl 3):S183-S185
43. Wada A, Ohnishi M, Tsutamoto T, Fujii M, Matsumoto T, Yamamoto T, Wang X, Kinoshita M 2002 Chronic effects of an endothelin-converting enzyme inhibitor on cardiorenal and hormonal function in heart failure. Clin Sci (Lond) 103(Suppl 48):254S-257S
44. Avighon A, Sultan A 2006 PKC-β inhibition: a new therapeutic approach for diabetic complications? Diabetes Metab 32:205-213
45. Orzechowski HD, Günther A, Menzel S, Zimmermann A, Funke-Kaiser H, Real R, Subkowski T, Zollmann FS, Paul M 2001 Transcriptional mechanism of protein kinase C-induced isoform-specific expression of the gene for endothelin-converting enzyme-1 in human endothelial cells. Mol Pharmacol 60:1332-1342
46. Xia P, Kramer RM, King GL 1995 Identification of the mechanism for the inhibition of Na +, K+-adenosine triphosphate by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest 96:733-740
47. Perez-Rivero G, Ruiz-Torres MP, Rivas-Elena JV, Jerkic M, Díez-Marques ML, Lopez-Novoa JM, Blasco MA, Rodríguez-Puyol D 2006 Mice deficient in tel omerase activity develop hypertension because of an excess of end othelin production. Circulation 114:309-317
48. Soh JW, Lee EH, Prywes R, Weinstein IB 1999 Novel roles of specific is oforms of protein kinase C in activation of the c-fos serum response element. Mol Cell Biol 19:1313-1324
49. Clermont AC, Brittis M, Shiba T, McGovern T, King GL, Bursell S-E 1994 Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps. Invest Ophthalmol Vis Sci 35:981-990